The Street’s view on Castle Biosciences has shifted, with the consensus analyst price target moving from about US$46.00 to ...
Atlantic Street Capital ("Atlantic Street" or "ASC"), a private equity firm that invests in lower middle market companies through an operationally intensive strategy, announced today the sale of GAT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results